Latest Japanese Market News

New Hope Corporation reports steady coal production but a 27% drop in EBITDA amid falling prices and rail constraints, prompting revised FY25 guidance.

IODM Limited has secured a new revenue share agreement with Converain targeting Japan’s growing international education market, marking its fourth such deal globally.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

New Hope Group delivered a robust quarterly performance with a 21.8% rise in underlying EBITDA and a 33% jump in saleable coal production for the first half of FY25, underpinned by operational efficiencies and strategic investments.